NRO Neurones SA

NEURONES: Organic growth up 2.6% in 2020

NEURONES: Organic growth up 2.6% in 2020

PRESS INFORMATION

Heading: 2020 Annual Revenues       Nanterre, February 10, 2021 (after the closing of the stock exchange)

Organic growth up 2.6% in 2020

(unaudited, in € millions)20192020Growthof which organic
Revenues510.1524.5+ 2.8%+ 2.6%

Achievements

During the 4th quarter, revenues grew by 5.3%, of which 4.6% with constant structures, continuing the 5.5% increase observed in the 3rd quarter.

Cloud and digital are driving growth, particularly cybersecurity (+ 55%) and data, mobility and digital workplace projects (+ 19%).

At € 51.9 million*, operating profit amounted to 9.9% of revenues (compared to 9.6%, excluding disposal gains, in 2019).

Cash generation was very satisfactory with a net cash** of € 265.9 million* at closing (+ € 47.6 million compared to the end of the previous fiscal year), notably thanks to a further reduction of seven days in the customer payment period.

The Group's payroll continued to grow (5,589 employees at the end of the year compared to 5,372 at the end of the previous fiscal year).

The final annual results will be published on Wednesday, March 3, 2021 after the stock exchange closes.

Outlook

As usual, forecasts for the current year will be posted along with the Group's 1st quarter revenues.

* being audited. ** excluding IFRS16 lease liabilities.

About NEURONES

With 5,600 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment B - NRO) - Enternext Tech 40 - SRD (deferred settlement) mid-caps

Press Relations:

O'Connection

Floriane Monnier

Tel.: +33 (0)6 32 37 57 28

 



NEURONES

Matthieu Vautier

Tel.: +33 (0)1 41 37 41 37

Investor Relations:

NEURONES

Paul-César Bonnel

Tel.: +33 (0)1 41 37 41 37

Attachment



EN
10/02/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE

NEURONES : Déclaration des transactions sur actions propres (période d...

NEURONES : Déclaration des transactions sur actions propres (période du 23 au 27 mars 2026) Nanterre, le 30 mars 2026 Déclaration des transactions sur actions propres(période du 23 au 27 mars 2026) Dans le cadre du programme de rachat d’actions propres autorisé par l’Assemblée Générale du 5 juin 2025 et confié au CIC, NEURONES a procédé, entre le 23 et le 27 mars 2026, aux achats suivants (code ISIN FR0004050250) : JourVolume total journalier(en nombre d'actions)Prix pondéré moyen(journalier unitaire)23/03/202646 39234,13 €24/03/202642 99333,47 €25/03/202611 66534,58 €26/03/20267 16634,2...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (March 23 to ...

NEURONES: Declaration of transactions on treasury shares (March 23 to 27, 2026) Nanterre, March 30, 2026 Declaration of transactions on treasury shares(period from 23 to 27 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between March 23 and 27, 2026 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)03/23/202646,39234.13 €03/24/202642,99333.47 €03/25/202611,66534.58 €03/26/20267,16634.26 €03/27/20266,80534.43 €Total115,021  As o...

 PRESS RELEASE

NEURONES : Déclaration des transactions sur actions propres (période d...

NEURONES : Déclaration des transactions sur actions propres (période du 16 au 20 mars 2026) Nanterre, le 23 mars 2026 Déclaration des transactions sur actions propres(période du 16 au 20 mars 2026) Dans le cadre du programme de rachat d’actions propres autorisé par l’Assemblée Générale du 5 juin 2025 et confié au CIC, NEURONES a procédé, entre le 16 et le 20 mars 2026, aux achats suivants (code ISIN FR0004050250) : JourVolume total journalier(en nombre d'actions)Prix pondéré moyen(journalier unitaire)16/03/202632 18634,17 €17/03/20266 80035,09 €18/03/20266 56735,05 €19/03/20266 38434,95 €...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (March 16 to ...

NEURONES: Declaration of transactions on treasury shares (March 16 to 20, 2026) Nanterre, March 23, 2026 Declaration of transactions on treasury shares(period from 16 to 20 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between March 16 and 20, 2026 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)03/16/202632,186€34.1703/17/20266,800€35.0903/18/20266,567€35,0503/19/20266,384€34,9503/20/202621,011€34,16Total72,948  As of March...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (March 9 to 1...

NEURONES: Declaration of transactions on treasury shares (March 9 to 13, 2026) Nanterre, March 16, 2026 Declaration of transactions on treasury shares(period from 9 to 13 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between March 9 and 13, 2026 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)03/12/202625,669€36.1003/13/20266,734€34.96Total32,403  As of March 13, 2026, excluding the liquidity contract, NEURONES now holds 42,...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch